EUVIMED · CrossrefJournal
JAMA Cardiology
ISSN 2380-6583 · American Medical Association (AMA)
Latest articles
Sex Differences in Quantified Mitral Regurgitation
Sex Differences in Quantified Mitral Regurgitation—Reply
Aging Populations and the Rising Burden of Cardiovascular Disease
First and Subsequent Major Cardiovascular Events With Oral Semaglutide in High-Risk Type 2 Diabetes
Assessment of Coronary Inflammatory Risk From Noncontrast Cardiac Computed Tomography
AI-Identified Reasons for Nonescalation of Lipid-Lowering Therapy for Secondary Prevention
Ebstein Anomaly With Pre-excited Atrial Fibrillation
Man in His 20s With A New Rash and Right Atrial Mass
Threshold Optimization Vs Assay Advancement
Threshold Optimization Vs Assay Advancement
Threshold Optimization Vs Assay Advancement
Threshold Optimization Vs Assay Advancement—Reply
Efficacy and Safety of Routine Postdilation in Balloon-Expandable Transcatheter Aortic Valve Implantation Platform
Routine Postdilation to Optimize Balloon-Expandable Valve Expansion
Atrial Pseudomasses in Erdheim-Chester Disease
Dynamic Mitral Obstruction by a Left-Sided Cardiac Sarcoma
The Future of Genetic Therapy for Inherited Cardiomyopathy
Remote Detection of Cardiac Implantable Electrical Devices
An Axillary Mass in Pulmonary Embolism
Pooled Prasugrel Doses in a P2Y12 Network Meta-Analysis
Pooled Prasugrel Doses in a P2Y12 Network Meta-Analysis—Reply
Undiagnosed Chronic Kidney Disease, Outcomes, and Finerenone in Heart Failure
Interpreting 7-Year Valve Durability in PARTNER 3
Interpreting 7-Year Valve Durability in PARTNER 3
Efficacy and Safety of Semaglutide According to Frailty Status
Interpreting 7-Year Valve Durability in PARTNER 3—Reply
Designing Cardiovascular Outcomes Trials in Clonal Hematopoiesis of Indeterminate Potential
Multidimensional Aging Trajectories Preceding Cardiovascular Events
Right Atrial Ectopic Hepatic Tissue at the Caval Inflow
EUVIMED